BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aguzzi A, Heikenwalder M, Miele G. Progress and problems in the biology, diagnostics, and therapeutics of prion diseases. J Clin Invest 2004;114:153-60. [PMID: 15254579 DOI: 10.1172/JCI22438] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ali T, Hannaoui S, Nemani S, Tahir W, Zemlyankina I, Cherry P, Shim SY, Sim V, Schaetzl HM, Gilch S. Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice. Acta Neuropathol Commun 2021;9:58. [PMID: 33795005 DOI: 10.1186/s40478-021-01162-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
2 Eraña H, Charco JM, González-Miranda E, García-Martínez S, López-Moreno R, Pérez-Castro MA, Díaz-Domínguez CM, García-Salvador A, Castilla J. Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases. Biomolecules 2020;10:E469. [PMID: 32204429 DOI: 10.3390/biom10030469] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Meneghetti E, Gasperini L, Virgilio T, Moda F, Tagliavini F, Benetti F, Legname G. Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases. Mol Neurobiol 2019;56:6035-45. [PMID: 30710214 DOI: 10.1007/s12035-019-1505-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ma Y, Shi Q, Wang J, Xiao K, Sun J, Lv Y, Guo M, Zhou W, Chen C, Gao C, Zhang BY, Dong XP. Reduction of NF-κB (p65) in Scrapie-Infected Cultured Cells and in the Brains of Scrapie-Infected Rodents. ACS Chem Neurosci 2017;8:2535-48. [PMID: 28783945 DOI: 10.1021/acschemneuro.7b00273] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
5 Park JH, Choi YG, Park SJ, Choi HS, Choi EK, Kim YS. Ultra-efficient Amplification of Abnormal Prion Protein by Modified Protein Misfolding Cyclic Amplification with Electric Current. Mol Neurobiol 2018;55:1630-8. [PMID: 28194643 DOI: 10.1007/s12035-017-0431-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Sushma B, Gugwad S, Pavaskar R, Malik SA. Prions in dentistry: A need to be concerned and known. J Oral Maxillofac Pathol 2016;20:111-4. [PMID: 27194872 DOI: 10.4103/0973-029X.180961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Park JH, Choi YG, Lee YJ, Park SJ, Choi HS, Choi KC, Choi EK, Kim YS. Real-Time Quaking-Induced Conversion Analysis for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease in Korea. J Clin Neurol 2016;12:101-6. [PMID: 26541494 DOI: 10.3988/jcn.2016.12.1.101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
8 Wang J, Zhang BY, Zhang J, Xiao K, Chen LN, Wang H, Sun J, Shi Q, Dong XP. Treatment of SMB-S15 Cells with Resveratrol Efficiently Removes the PrP(Sc) Accumulation In Vitro and Prion Infectivity In Vivo. Mol Neurobiol 2016;53:5367-76. [PMID: 26440667 DOI: 10.1007/s12035-015-9464-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
9 Hannaoui S, Shim SY, Cheng YC, Corda E, Gilch S. Cholesterol balance in prion diseases and Alzheimer's disease. Viruses 2014;6:4505-35. [PMID: 25419621 DOI: 10.3390/v6114505] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
10 Villa V, Thellung S, Corsaro A, Novelli F, Tasso B, Colucci-D'Amato L, Gatta E, Tonelli M, Florio T. Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells. Mol Neurobiol 2016;53:57-72. [PMID: 25404089 DOI: 10.1007/s12035-014-8982-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
11 Sobrova P, Blazkova I, Chomoucka J, Drbohlavova J, Vaculovicova M, Kopel P, Hubalek J, Kizek R, Adam V. Quantum dots and prion proteins: is this a new challenge for neurodegenerative diseases imaging? Prion 2013;7:349-58. [PMID: 24055838 DOI: 10.4161/pri.26524] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
12 Haybaeck J, Heikenwalder M, Klevenz B, Schwarz P, Margalith I, Bridel C, Mertz K, Zirdum E, Petsch B, Fuchs TJ, Stitz L, Aguzzi A. Aerosols transmit prions to immunocompetent and immunodeficient mice. PLoS Pathog 2011;7:e1001257. [PMID: 21249178 DOI: 10.1371/journal.ppat.1001257] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
13 Hnasko R, Serban AV, Carlson G, Prusiner SB, Stanker LH. Generation of antisera to purified prions in lipid rafts. Prion 2010;4:94-104. [PMID: 20647769 DOI: 10.4161/pri.4.2.12622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
14 Mahillo-Fernandez I, de Pedro-Cuesta J, Bleda MJ, Cruz M, Mølbak K, Laursen H, Falkenhorst G, Martínez-Martín P, Siden A; EUROSURGYCJD Research Group. Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology 2008;31:229-40. [PMID: 18843192 DOI: 10.1159/000163097] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
15 Seeger H, Julius C, Cozzari C, Calella AM, Dattilo M, Aguzzi A. Prion depletion and preservation of biological activity by preparative chaotrope ultracentrifugation. Biologicals 2008;36:403-11. [PMID: 18760936 DOI: 10.1016/j.biologicals.2008.07.004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Schneider DA, Yan H, Fry LM, Alverson J, White SN, O'Rourke KI. Myenteric neurons of the ileum that express somatostatin are a target of prion neuroinvasion in an alimentary model of sheep scrapie. Acta Neuropathol 2008;115:651-61. [PMID: 18427817 DOI: 10.1007/s00401-008-0374-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
17 Pani A, Norfo C, Abete C, Mulas C, Putzolu M, Laconi S, Orrù CD, Cannas MD, Vascellari S, La Colla P, Dessì S. Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines. Antimicrob Agents Chemother 2007;51:4141-7. [PMID: 17709472 DOI: 10.1128/AAC.00524-07] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
18 Zuber C, Mitteregger G, Pace C, Zerr I, Kretzschmar HA, Weiss S. Anti-LRP/LR antibody W3 hampers peripheral PrPSc propagation in scrapie infected mice. Prion 2007;1:207-12. [PMID: 19164931 DOI: 10.4161/pri.1.3.5273] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
19 Piccardo P, Manson JC, King D, Ghetti B, Barron RM. Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc Natl Acad Sci U S A 2007;104:4712-7. [PMID: 17360589 DOI: 10.1073/pnas.0609241104] [Cited by in Crossref: 142] [Cited by in F6Publishing: 128] [Article Influence: 9.5] [Reference Citation Analysis]
20 Pfeifer A, Eigenbrod S, Al-Khadra S, Hofmann A, Mitteregger G, Moser M, Bertsch U, Kretzschmar H. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. J Clin Invest 2006;116:3204-10. [PMID: 17143329 DOI: 10.1172/JCI29236] [Cited by in Crossref: 107] [Cited by in F6Publishing: 91] [Article Influence: 7.1] [Reference Citation Analysis]
21 Cooper SA, Murray KL, Heath CA, Will RG, Knight RS. Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK. J Neurol Neurosurg Psychiatry 2006;77:1273-5. [PMID: 16835290 DOI: 10.1136/jnnp.2006.088930] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
22 Donofrio G, Heppner FL, Polymenidou M, Musahl C, Aguzzi A. Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies. J Virol 2005;79:8330-8. [PMID: 15956578 DOI: 10.1128/JVI.79.13.8330-8338.2005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]